Release of nitrogen oxides from cultured bovine aortic endothelial cells is not impaired by calcium channel antagonists.
Author(s) -
Andreas Mügge,
Timothy E. Peterson,
DONNA HARRISON
Publication year - 1991
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.83.4.1404
Subject(s) - nitric oxide , bradykinin , verapamil , calcium , calcium channel , nitric oxide synthase , extracellular , biochemistry , endothelium , endothelium derived relaxing factor , medicine , pharmacology , chemistry , receptor
The endothelium-derived relaxing factor has been shown to be nitric oxide or a related nitroso compound, synthesized by the enzyme nitric oxide synthetase, which oxidizes the guanidono nitrogens of arginine. This enzyme is activated by increases in cytosolic calcium. The effect of the clinically used calcium channel antagonists on this process is controversial. The present study was performed to determine whether calcium channel blockade with these pharmacologic agents would alter the activity of nitric acid synthetase in intact endothelial cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom